Springer Science and Business Media LLC
SCIE-ISI SCOPUS (2002-2025)
1475-2840
Cơ quản chủ quản: BioMed Central Ltd. , BMC
Lĩnh vực:
Internal MedicineEndocrinology, Diabetes and MetabolismCardiology and Cardiovascular Medicine
Phân tích ảnh hưởng
Các bài báo tiêu biểu
Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
Tập 8 Số 1 - Trang 35 - 2009
Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
Tập 15 Số 1 - 2016
Vascular ossification – calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis – calcific uremic arteriolopathy: the emerging role of sodium thiosulfate
- 2005
AbstractBackgroundVascular calcification is associated with metabolic syndrome,
diabetes, hypertension, atherosclerosis, chronic kidney disease, and end stage
renal disease. Each of the above contributes to an accelerated and premature
demise primarily due to cardiovascular disease. The above conditions are
associated with multiple metabolic toxicities resulting in an increase in
reactive oxygen s...
Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus
Tập 12 Số 1 - 2013
Abstract Background Fluctuations in blood glucose level cause endothelial
dysfunction and play a critical role in onset and/or progression of
atherosclerosis. We hypothesized that fluctuation in blood glucose levels
correlate with vascular endothelial dysfunction and that this relationship can
be assessed using common bedside medical devices. Methods Fluctuations in blood
glucose levels were measu...
Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state
- 2006
Abstract Obstructive sleep apnoea (OSA) is a cardio-metabolic disorder. Whether
metabolic syndrome (MS), insulin resistance (IR) and albuminuria are
independently associated with OSA is unclear, but defining the interactions
between OSA and various cardiovascular (CV) risk factors independent of obesity
facilitates the development of therapeutic strategies to mitigate their
increased CV risks. We ...
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Tập 13 Số 1 - Trang 65 - 2014
Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis
Tập 15 Số 1 - 2016
Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies
- 2021
Abstract Background Insulin resistance has been demonstrated to be involved in
the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study
evaluated the association between the triglyceride–glucose (TyG) index, a novel
surrogate indicator of insulin resistance, and the incidence of ASCVDs in people
without ASCVDs at baseline by performing a meta-analysis. Methods Cohort studie...
Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity
Tập 19 Số 1 - 2020
AbstractSevere obesity among children and adolescents is a significant global
public health concern. The prevalence has markedly increased over the last
decades, becoming common in many countries. Overwhelming rates of obesity among
youth have prompted efforts to identify an evidence-based immediate- and
long-term cardiometabolic risk factor profile in childhood-onset severe obesity,
and to highli...